World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
65
Citations
19764
World Ranking
2811
National Ranking
1328

Overview

Michael A. Polis is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research spans across multiple fields of study, primarily focusing on Medicine with notable work in subfields such as Pathology and Forensic Medicine, Infectious Diseases, Nutrition and Dietetics, and Hepatology.

The scientist's research covers a range of topics including:

  • Vitamin D Research Studies
  • COVID-19 Clinical Research Studies
  • Vitamin C and Antioxidants Research
  • Hepatitis C virus research

Michael A. Polis has published work in several academic venues, with recent publications appearing in:

  • JAMA Network Open
  • UNC Libraries

Some of their recent papers include:

  • Reassessing the Association of Vitamin D Level With SARS-CoV-2 Seropositivity, 2021, JAMA Network Open
  • Gene Expression Profiles Predict Emergence of Psychiatric Adverse Events in HIV/HCV-Coinfected Patients on Interferon-Based HCV Therapy, 2020, UNC Libraries

Frequent co-authors collaborating with Michael A. Polis include:

  • Joseph J. Rasimas
  • Antonios Katsounas
  • Haniya Raza
  • Alison Murphy
  • Jun Yang

Michael A. Polis's contributions have engaged with clinical and molecular aspects of infectious diseases and nutritional biochemistry, as indicated by their work on vitamin D and COVID-19 seropositivity as well as hepatitis C virus therapy. The research ties aspects of nutrition and immune response, highlighting interdisciplinary connections within their scientific inquiries.

Best Publications

  • Changes in thymic function with age and during the treatment of HIV infection

    Daniel C. Douek;Richard D. McFarland;Phillip H. Keiser;Earl A. Gage

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection.

    H Masur;F P Ognibene;R Yarchoan;J H Shelhamer

  • New Real-Time Reverse Transcriptase-Initiated PCR Assay with Single-Copy Sensitivity for Human Immunodeficiency Virus Type 1 RNA in Plasma

    Sarah Palmer;Ann P. Wiegand;Frank Maldarelli;Holly Bazmi

  • Guidelines for preventing opportunistic infections among HIV-infected persons - 2002

    Henry Masur;Jonathan E. Kaplan;King K. Holmes;Beverly Alston

  • USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus

    David Lanier;Neil Schram;Ellen Cooper;Kenneth A. Freedberg

  • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

    Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon

  • Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.

    J A Kovacs;M Baseler;R J Dewar;S Vogel

  • Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo

    Francesco R. Simonetti;Michele D. Sobolewski;Elizabeth Fyne;Wei Shao

  • A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS

    A G Palestine;M A Polis;M D De Smet;B F Baird

  • Sofosbuvir and ribavirin for hepatitis C genotype 1 in patients with unfavorable treatment characteristics: a randomized clinical trial.

    Anuoluwapo Osinusi;Eric G. Meissner;Yu Jin Lee;Dimitra Bon

  • ART Suppresses Plasma HIV-1 RNA to a Stable Set Point Predicted by Pretherapy Viremia

    Frank Maldarelli;Sarah Palmer;Martin S King;Ann Wiegand

  • Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.

    Robert E. Walker;Christine M. Bechtel;Ven Natarajan;Michael Baseler

  • Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

    H. Clifford Lane;Victoria Davey;Joseph A. Kovacs;Judith Feinberg

  • High Prevalence of Osteonecrosis of the Femoral Head in HIV-Infected Adults

    Kirk D Miller;Henry Masur;Elizabeth C Jones;Galen O Joe

  • Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV.

    Joseph A. Kovacs;Richard A. Lempicki;Igor A. Sidorov;Joseph W. Adelsberger

  • Virologic Response Following Combined Ledipasvir and Sofosbuvir Administration in Patients With HCV Genotype 1 and HIV Co-infection

    Anu Osinusi;Anu Osinusi;Kerry Townsend;Anita Kohli;Anita Kohli;Amy Nelson;Amy Nelson

  • Clinical Pharmacokinetics of Cidofovir in Human Immunodeficiency Virus-Infected Patients

    K. C. Cundy;B. G. Petty;J. Flaherty;P. E. Fisher

  • Idiopathic CD4+ lymphocytopenia: natural history and prognostic factors

    Dimitrios I. Zonios;Judith Falloon;John E. Bennett;Pamela A. Shaw

  • Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patients.

    Richard A. Lempicki;Joseph A. Kovacs;Michael W. Baseler;Joseph W. Adelsberger

Frequent Co-Authors

Henry Masur
Henry Masur National Institutes of Health
Richard T. Davey
Richard T. Davey National Institute of Allergy and Infectious Diseases
Shyam Kottilil
Shyam Kottilil University of Maryland, Baltimore
Joseph A. Kovacs
Joseph A. Kovacs National Institutes of Health
H. Clifford Lane
H. Clifford Lane National Institute of Allergy and Infectious Diseases
Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
Richard A. Lempicki
Richard A. Lempicki National Institute of Allergy and Infectious Diseases
Michael Baseler
Michael Baseler Leidos (United States)
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Eva Herrmann
Eva Herrmann Goethe University Frankfurt

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Immunology, expanding knowledge through related healthcare degrees can open diverse career opportunities. Many professionals pursue nursing pathways that complement immunological expertise, such as becoming a Nurse Practitioner (NP). Exploring an accelerated NP program offers a fast track to advanced clinical roles, helping individuals transition into specialized fields efficiently.

Those currently working as Family Nurse Practitioners (FNPs) can enhance their skills by pursuing acute care nurse practitioner certification. This certification enables nurses to work in critical care settings, often related to immunology cases like infectious diseases and immune system disorders.

For newcomers without a nursing background, 12-month accelerated nursing programs online for non nurses provide a valuable pathway to enter the nursing profession quickly and build foundational knowledge applicable to immunology careers.

Salary prospects are also an important consideration. Understanding how much does a dnp make can help guide career and educational decisions, especially for those aiming to maximize their earning potential while contributing to healthcare advancements in immunology.

Best Scientists Citing Michael A. Polis

Trending Scientists

Recently Published Articles